Clinical Trial

PAH Exercise Study

Name: PAH Exercise Study — clinical trial record (NCT06941441)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

Ten patients with PAH who are stable and eligible to initiate sotatercept therapy will participate in a 26 week study that consists of a 24-week intervention period where patients will receive complimentary sotatercept as prescribed, plus a tailored, progressive home exercise program with wrist-worn fitness tracker and oxygen saturation monitoring.

Trial Details

NCT Number	NCT06941441
Lead Sponsor	University of Washington
Conditions	Pulmonary Arterial Hypertension (PAH), Exercise Therapy
Enrollment	10 participants
Start Date	2025-04-15
Primary Completion	2026-09-30 (estimated)
Study Completion	2026-09-30 (estimated)
Updated on ClinicalTrials.gov	2025-04-23